Human Low affinity immunoglobulin gamma Fc region receptor III-B(FCGR3B) ELISA kit

Tissue:

region

Notes:

For research use only.

Specifications:

Detection range: 1.56 ng/mL-100 ng/mL; Sensitivity: 0.39 ng/mL

Additional_information:

Sample volume: 50-100ul; Detection wavelength: 450nm; Assay performance time: 1 to 4 hours.

Storage_and_shipping:

Transported on ice packs/blue ice. Keep refrigerated at 2-8 degrees Celsius. Shelf life: 6 months.

Description:

Quantitativesandwich ELISA kit for measuring Human Low affinity immunoglobulin gamma Fc region receptor III-B(FCGR3B) in samples from serum, plasma, tissue homogenates

Test:

A high affinity purification column was use to purify immunoglobulin gamma Fc region receptor III-B(FCGR3B) ELISA kit by Cusabio by chromatographic size exclusion.ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED

Properties:

E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.

Additional description:

The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.